292 related articles for article (PubMed ID: 26152702)
1. Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicity.
Wiczer T; Dotson E; Tuten A; Phillips G; Maddocks K
J Oncol Pharm Pract; 2016 Jun; 22(3):430-6. PubMed ID: 26152702
[TBL] [Abstract][Full Text] [Related]
2. High-dose methotrexate in adult oncology patients: a case-control study assessing the risk association between drug interactions and methotrexate toxicity.
Chan AJ; Rajakumar I
J Oncol Pharm Pract; 2014 Apr; 20(2):93-9. PubMed ID: 23698198
[TBL] [Abstract][Full Text] [Related]
3. Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High-Dose Methotrexate.
Drost SA; Wentzell JR; Giguère P; McLurg DL; Sabloff M; Kanji S; Nguyen TT
Pharmacotherapy; 2017 Jun; 37(6):684-691. PubMed ID: 28394433
[TBL] [Abstract][Full Text] [Related]
4. Preventing and Managing Toxicities of High-Dose Methotrexate.
Howard SC; McCormick J; Pui CH; Buddington RK; Harvey RD
Oncologist; 2016 Dec; 21(12):1471-1482. PubMed ID: 27496039
[TBL] [Abstract][Full Text] [Related]
5. Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma.
Mir O; Ropert S; Babinet A; Alexandre J; Larousserie F; Durand JP; Enkaoua E; Anract P; Goldwasser F
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1059-63. PubMed ID: 20155268
[TBL] [Abstract][Full Text] [Related]
6. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
Widemann BC; Balis FM; Murphy RF; Sorensen JM; Montello MJ; O'Brien M; Adamson PC
J Clin Oncol; 1997 May; 15(5):2125-34. PubMed ID: 9164227
[TBL] [Abstract][Full Text] [Related]
7. Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure.
van den Bongard HJ; Mathĵt RA; Boogerd W; Schornagel JH; Soesan M; Schellens JH; Beijnen JH
Cancer Chemother Pharmacol; 2001 Jun; 47(6):537-40. PubMed ID: 11459208
[TBL] [Abstract][Full Text] [Related]
8. Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia.
Reiss SN; Buie LW; Adel N; Goldman DA; Devlin SM; Douer D
Ann Hematol; 2016 Dec; 95(12):2009-2015. PubMed ID: 27542957
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for high-dose methotrexate associated acute kidney injury in patients with hematological malignancies.
Amitai I; Rozovski U; El-Saleh R; Shimony S; Shepshelovich D; Rozen-Zvi B; Raanani P; Gafter-Gvili A; Gurion R
Hematol Oncol; 2020 Oct; 38(4):584-588. PubMed ID: 32506594
[TBL] [Abstract][Full Text] [Related]
10. Successful high-dose methotrexate chemotherapy in a patient with acute lymphocytic leukemia who developed acute renal failure during the initial treatment.
Isoda T; Ito S; Kajiwara M; Nagasawa M
Pediatr Int; 2007 Dec; 49(6):1018-9. PubMed ID: 18045317
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for high-dose methotrexate-induced nephrotoxicity.
Kawaguchi S; Fujiwara SI; Murahashi R; Nakashima H; Matsuoka S; Ikeda T; Toda Y; Ito S; Ban T; Nagayama T; Umino K; Minakata D; Nakano H; Yamasaki R; Ashizawa M; Yamamoto C; Hatano K; Sato K; Oh I; Ohmine K; Kanda Y
Int J Hematol; 2021 Jul; 114(1):79-84. PubMed ID: 33743109
[TBL] [Abstract][Full Text] [Related]
12. [Managing methotrexate toxicity: a case report].
Fernández Megía MJ; Alós Almiñana M; Terol Castera MJ
Farm Hosp; 2004; 28(5):371-4. PubMed ID: 15504095
[TBL] [Abstract][Full Text] [Related]
13. [Renal toxicity of high-dose methotrexate].
Garcia H; Leblond V; Goldwasser F; Bouscary D; Raffoux E; Boissel N; Broutin S; Joly D
Nephrol Ther; 2018 Apr; 14 Suppl 1():S103-S113. PubMed ID: 29606256
[TBL] [Abstract][Full Text] [Related]
14. Effect of single agent high-dose methotrexate-related acute kidney injury on length of hospitalization and relative dose intensity in adult patients with central nervous system lymphoma.
Steward JS; Bullard HM; O'Rourke TJ; Campbell AD; Brinker BT; Yost KJ; Vanderwoude AC; Scott WL; Kintzel PE
J Oncol Pharm Pract; 2017 Oct; 23(7):496-501. PubMed ID: 27543094
[TBL] [Abstract][Full Text] [Related]
15. Renal dysfunction during and after high-dose methotrexate.
Green MR; Chamberlain MC
Cancer Chemother Pharmacol; 2009 Mar; 63(4):599-604. PubMed ID: 18504579
[TBL] [Abstract][Full Text] [Related]
16. A second administration of glucarpidase in a different cycle of high-dose methotrexate: Is it safe and effective in adults?
Domingo-González A; Osorio S; Landete E; Monsalvo S; Díez-Martín JL
J Oncol Pharm Pract; 2021 Apr; 27(3):734-738. PubMed ID: 32731844
[TBL] [Abstract][Full Text] [Related]
17. High incidence of methotrexate associated renal toxicity in patients with lymphoma: a retrospective analysis.
May J; Carson KR; Butler S; Liu W; Bartlett NL; Wagner-Johnston ND
Leuk Lymphoma; 2014 Jun; 55(6):1345-9. PubMed ID: 24004183
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy.
Widemann BC; Schwartz S; Jayaprakash N; Christensen R; Pui CH; Chauhan N; Daugherty C; King TR; Rush JE; Howard SC
Pharmacotherapy; 2014 May; 34(5):427-39. PubMed ID: 24132809
[TBL] [Abstract][Full Text] [Related]
19. Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity.
Tuffaha HW; Al Omar S
J Oncol Pharm Pract; 2011 Jun; 17(2):136-40. PubMed ID: 19833686
[TBL] [Abstract][Full Text] [Related]
20. Carboxypeptidase G2 rescue in a 79 year-old patient with cranial lymphoma after high-dose methotrexate induced acute renal failure.
Krackhardt A; Schwartz S; Korfel A; Thiel E
Leuk Lymphoma; 1999 Nov; 35(5-6):631-5. PubMed ID: 10609804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]